The immunosuppressant drug Cyclosporin A aggravates irradiation effects in endothelial cells

Biochem Biophys Res Commun. 2022 Apr 30:602:127-134. doi: 10.1016/j.bbrc.2022.02.096. Epub 2022 Feb 25.

Abstract

The immunosuppressant drug Cyclosporin A (CsA) has been widely used to prevent the development of Graft-versus-Host Disease (GvHD) that can occur after transplantation, including allogeneic graft after accidental high-dose irradiation in humans. Here, we show that CsA alone stimulates ICAM-1 overexpression in human pulmonary microvascular endothelial cells (HPMECs) through Toll-Like Receptor 4 (TLR4) and NF-κB activation. In HPMECs, CsA treatment significantly worsened the overexpression of ICAM-1 induced by high-dose irradiation (15 Gy). This additive effect of CsA was also observed when ICAM-1 overexpression was induced by another pathway (Ca2+ entry) in macrovascular endothelial cells. In addition, CsA triggered apoptosis as well as rearrangement of the actin cytoskeleton and adherens junctions (VE-Cadherin) in microvascular endothelial monolayers. High-dose irradiation triggered similar deleterious effects in endothelial monolayers and, again, CsA treatment strongly aggravated the effects of irradiation. Altogether, these results suggest that post-transplant CsA treatment may exacerbate the deleterious effects of irradiation on the endothelium.

Keywords: Actin cytoskeleton; Apoptosis; Cyclosporin A; Endothelial cells; ICAM-1; VE-Cadherin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cadherins / metabolism
  • Cyclosporine* / pharmacology
  • Endothelial Cells / metabolism
  • Graft vs Host Disease*
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Intercellular Adhesion Molecule-1 / metabolism

Substances

  • Cadherins
  • Immunosuppressive Agents
  • Intercellular Adhesion Molecule-1
  • Cyclosporine